Brief: Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season
27/08/2026 22:43
BRIEF-Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season Aug 28 (Reuters) - Sanofi Spokesperson:
NUVAXOVID WILL BE AVAILABLE ACROSS U.S. FOR THE 2026-2027 RESPIRATORY VIRUS SEASON- SANOFI SPOKESPERSON
WELCOME APPROVAL OF UPDATED FORMULATION OF NUVAXOVID FOR USE DURING 2026-2027 RESPIRATORY VIRUS SEASON - SANOFI SPOKESPERSON
Source text: [ID:]
Further company coverage: SASY.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novavax
See all newsNovavax shareholder Shah Capital to step back from activist role
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects
Brief: Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season
US FDA approves updated COVID vaccines for 2026-27 season
US STOCKS-Wall St rises as yields ease, Moderna lifts healthcare stocks